Cell Death & Disease
After the technical scheme disclosed by the invention is adopted, a semaglutide product can be rapidly, efficiently and highly specifically obtained, and meanwhile, a large number of chemical reagents are not needed, so that the method is a green and environment-friendly preparation method
A core highlight includes the Phase 3 ACHIEVE trial results for Foundayo, an oral small-molecule GLP-1 receptor agonist taken without food or water restrictions
Al-Rasheed, N.M
The adoption of oral semaglutide resulted in a significant reduction in the use of sulfonylureas, pioglitazone, DPP4 inhibitors, and insulin, with no substantial change in the utilization of SGLT2 inhibitors
This finding suggested us the possibility of cessation of a local IgE-mediated response to the drug after the desensitization protocol which is uncommon in most of the desensitization procedures